Wu H.JIN-YUAN SHIHCHIH-HSIN YANG2020-08-132020-08-1320151556-0864https://www.scopus.com/inward/record.uri?eid=2-s2.0-84940107951&doi=10.1097%2fJTO.0000000000000611&partnerID=40&md5=c068b16f6f766e04715a88f43f639bf4https://scholars.lib.ntu.edu.tw/handle/123456789/512635[SDGs]SDG3antibiotic agent; cisplatin; docetaxel; epidermal growth factor receptor; erlotinib; pemetrexed; protein Ret; steroid; sunitinib; antineoplastic agent; indole derivative; KIF5B-RET fusion protein, human; oncoprotein; pyrrole derivative; sunitinib; adult; bone metastasis; brain metastasis; cancer cell; cancer combination chemotherapy; cancer fatigue; cancer therapy; carcinomatosis; case report; computer assisted tomography; disease course; dyspnea; female; fusion gene; genetic analysis; human; intubation; kinesin family member 5b gene; Letter; leukopenia; lung adenocarcinoma; lung metastasis; lymphangitis; malignant pleura effusion; medical history; middle aged; multiple cancer; neutropenia; oncogene ret; outcome assessment; personal experience; pleura effusion; pneumonia; priority journal; respiratory distress; respiratory failure; reverse transcription polymerase chain reaction; thorax radiography; thrombocytopenia; treatment refusal; treatment response; adenocarcinoma; genetics; Lung Neoplasms; metabolism; Adenocarcinoma; Antineoplastic Agents; Female; Humans; Indoles; Lung Neoplasms; Middle Aged; Oncogene Proteins, Fusion; Pyrrolesletter10.1097/JTO.0000000000000611262910232-s2.0-84940107951